Menu

Alzheimer's

January 9, 2026 • Press Releases

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies

Washington D.C., Jan 9, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, to the Bio-Hermes studies. This collaboration will enhance the unique, observational platform studies that compare blood-based and digital biomarkers across a broad range of clinical […]

Alzheimer's Alzheimers Bio-Hermes Bio-Hermes-002 biomarkers GAP Research
December 23, 2025 • Press Releases

Clinical Neurology Specialists Partnering with Leading International Nonprofit to Accelerate Alzheimer’s Research in Las Vegas

Collaboration to Improve Access to Study for Alzheimer’s Disease Las Vegas, Nev. – Dec. 23 2025 – Today, Global Alzheimer’s Platform Foundation® (GAP) and Clinical Neurology Specialists (CNS) announced their collaboration to accelerate Alzheimer’s disease research in Las Vegas. CNS has joined the GAP-sponsored study, Bio-Hermes-002, a unique, observational platform study that compares blood-based and digital biomarkers […]

Alzheimer's Alzheimers Bio-Hermes-002 CNS GAP Research
December 20, 2025 • In the News

WPBF: ‘It’s the best time’: Family members may notice signs of Alzheimer’s at holiday gatherings

20 Dec ‘It’s the best time’: Family members may notice signs of Alzheimer’s at holiday gatherings Posted at 20:23h in Uncategorized by Belinda Russell 0 Comments ATLANTIS, Fla. — It’s the holiday season and while you celebrate with friends and family some experts say you may also notice some changes in elderly loved ones you haven’t seen for a while. Dr. Linda […]

Alzheimer's Alzheimers Bio-Hermes biomarkers GAP Research
December 10, 2025 • In the News

Think Global Health: A New Era for Alzheimer’s Disease Diagnosis

Aging Emerging biomarkers and digital tools are unlocking earlier and more accurate diagnosis Teresa, 75, an Alzheimer’s patient and former businesswoman, poses for a photograph inside the Alzheimer Foundation, in Mexico City, Mexico, on April 19, 2012.REUTERS/Edgard Garrido by Lydia Wu, Jennifer Panlilio, Melissa Lee, Laura Nisenbaum, Aishu Sukumar December 10, 2025 Alzheimer’s disease and related dementias affect more than […]

Alzheimer's Alzheimers Bio-Hermes biomarkers GAP Innovation Research
November 25, 2025 • Press Releases

GAP Statement following the release of top-line updates from two Alzheimer’s clinical trials

The Global Alzheimer’s Platform Foundation® (GAP) today issued a statement following the release of top-line updates from two Alzheimer’s clinical trials: Recently, developments in two important Alzheimer’s clinical research studies were reported. The two studies were: Novo Nordisk’s Phase 3 EVOKE and EVOKE+ trials evaluating oral semaglutide, and Johnson & Johnson’s Phase 2b trial evaluating the […]

Alzheimer's Alzheimers GAP Research
November 25, 2025 • In the News

Us Against Alzheimer’s Brainstorm Podcast: Ep 98: The Future of Alzheimer’s Trials: Bringing Cutting-Edge Research to Every Community – John Dwyer, CEO of The Global Alzheimer’s Platform

About This Episode The quest to speed up clinical trials is personal for John Dwyer, CEO of the Global Alzheimer’s Platform (GAP). A long-time UsA2 advocate, he’s been motivated by the generations of family members lost to Alzheimer’s and Parkinson’s disease. Dwyer shares with BrainStorm host Meryl Comer the critical challenges of NIH funding cuts […]

Alzheimer's Alzheimers biomarkers GAP Innovation Research
November 20, 2025 • In the News

Targeted News Service: Buchanan, Tonko Introduce Bipartisan, Bicameral Legislation to Expand Alzheimer’s Screening and Prevention

November 19, 2025 Delivers Life-Changing Early Detection for 580,000 Floridians Living with Alzheimer’s WASHINGTON — Today, Congressman Vern Buchanan, Vice Chairman of the House Ways and Means Committee and Chair of the Health Subcommittee, announced the introduction of the Alzheimer’s Screening and Prevention (ASAP) Act alongside Congressman Paul Tonko (D-N.Y.). Senators Susan Collins (R-Maine) and Catherine Cortez Masto (D-Nev.) introduced companion legislation in the Senate. This bipartisan, bicameral […]

Alzheimer's Alzheimers GAP Research
November 19, 2025 • Letter from the President

GAP’s 2025 IRI Virtual Conference

Last week, the Global Alzheimer’s Platform Foundation’s (GAP) Inclusive Research Initiative (IRI) team hosted its second annual virtual conference focused on improving Alzheimer’s and dementia research by increasing diversity among participants in neurodegenerative clinical trials. We are proud to have created a platform for meaningful dialogue and hope it has inspired new ideas, collaborations, and opportunities for those […]

Alzheimer's GAP Innovation Research
November 12, 2025 • In the News

KYMA: Imperial County researchers take Mobile Research Unit on the road to hold free memory assessments

IMPERIAL COUNTY, Calif. (KYMA) – The Sun Valley Research Center (SVRC) is taking a Mobile Research Unit on the road to hold free memory assessments. According to a press release, THOR (Taking Health on the Road) West is touring California and Arizona in order to help raise awareness of the importance of brain health.According to […]

Alzheimer's Alzheimers GAP Innovation Mobile Research Unit Research
October 29, 2025 • In the News

Politico: Closing the Gap

How the U.S. can drive progress into the next era of Alzheimer’s disease careSponsored by Lilly Today, over 7 million Americans are living with Alzheimer’s disease — a number that is expected to more than double by 2060, according to the Alzheimer’s Association. The stakes for the U.S. health care system have never been higher. A […]

Alzheimer's Alzheimers GAP Research